Mark Saunders
4Patents
2h-index
15Co-inventors
37Inventor score
Filing activity: Apr 22, 2014 → Feb 21, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9393202B2 | Particle size reduction of an antimuscarinic compound | Human Necessities | 2 | Active |
| US11142518B2 | 6-pyrimidin-isoindole derivative as ERK1/2 inhibitor | Chemistry; Metallurgy | 2 | Active |
| US9889094B2 | Particle size reduction of an antimuscarinic compound | Human Necessities | 0 | Active |
| US11844860B2 | Pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.